JAC Advance Access originally published online on January 6, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 427-429
© 2003 The British Society for Antimicrobial Chemotherapy
Growing antimicrobial resistance of Shigella isolates
1 Department of Paediatrics A and 2 Unit of Infectious Diseases, Schneider Childrens Medical Center of Israel, 14 Kaplan Street, Petah Tiqva 49202; 3 Felsenstein Medical Research Centre, Petah Tiqva; 4 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; 5 Department of Clinical Microbiology, Rabin Medical Center, Petah Tiqva, Israel
Received 19 July 2002; returned 26 September 2002; revised 6 November 2002; accepted 7 November 2002
Appropriate antibiotic treatment of shigellosis depends on identifying resistance patterns. By studying Shigella isolates in central Israel from 1998 to 2000, and comparing with the period 19911992, we identified a significantly increased resistance to tetracycline (from 23% to 87%, P < 0.00001), high resistance to trimethoprimsulfamethoxazole (94%) and ampicillin (85%) and emerging resistance to quinolones (0.52%). These data mandate local monitoring of resistance and its consideration in empirical therapy.
Keywords: diarrhoea, shigellosis, antibiotic therapy
* Corresponding author. Tel: +972-3-9253680; Fax: +972-3-9253056; E-mail: ashai{at}post.tau.ac.il
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Mandomando, D. Jaintilal, M. J. Pons, X. Valles, M. Espasa, L. Mensa, B. Sigauque, S. Sanz, J. Sacarlal, E. Macete, et al. Antimicrobial Susceptibility and Mechanisms of Resistance in Shigella and Salmonella Isolates from Children under Five Years of Age with Diarrhea in Rural Mozambique Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2450 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Pazhani, S. K. Niyogi, A. K. Singh, B. Sen, N. Taneja, M. Kundu, S. Yamasaki, and T. Ramamurthy Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India J. Med. Microbiol., July 1, 2008; 57(7): 856 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, Y. Yoshikawa, H. Ashida, H. Iwai, T. Toyotome, H. Matsui, and C. Sasakawa High Vaccine Efficacy against Shigellosis of Recombinant Noninvasive Shigella Mutant That Expresses Yersinia Invasin J. Immunol., October 1, 2006; 177(7): 4709 - 4717. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Farshad, R. Sheikhi, A. Japoni, E. Basiri, and A. Alborzi Characterization of Shigella Strains in Iran by Plasmid Profile Analysis and PCR Amplification of ipa Genes. J. Clin. Microbiol., August 1, 2006; 44(8): 2879 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Pan, R. Ye, D.-M. Meng, W. Zhang, H.-Q. Wang, and K.-Z. Liu Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri J. Antimicrob. Chemother., August 1, 2006; 58(2): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Lee, M.-C. Liu, C.-F. Ko, C.-H. Lu, and Y.-H. Tseng Molecular Epidemiology of Shigella flexneri in a Long-Stay Psychiatric Nursing Center during 2001 to 2003 J. Clin. Microbiol., March 1, 2005; 43(3): 1353 - 1360. [Abstract] [Full Text] [PDF] |
||||




